Ondrej Havranek

15PUBLICATIONS
63CO-AUTHORS
Haematological tumoursPredictive and prognostic markersOptical properties of materialsMolecular targetsAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Feb 13, 2026
Unlocking the Secrets of Regulated Cell Death in Large B-Cell Lymphoma Beyond Apoptosis: Signaling Pathways and Therapeutic Options.

Anton Tkachenko, Ondrej Havranek

|Feb 11, 2026
Inhibition of autoantigen-induced B-cell receptor (BCR) internalization as a therapeutic strategy in diffuse large B cell lymphoma (DLBCL).

Patryk Górniak, Anna Polak, Anna Rams

|Sep 08, 2025
Circulating tumour DNA as a predictor of survival of patients with diffuse large B-cell lymphoma in a daily practice.

Prokop Vodicka, Iva Hamova, Adriana Velasova

|Jul 01, 2025
Current understanding of eryptosis: mechanisms, physiological functions, role in disease, pharmacological applications, and nomenclature recommendations.

Anton Tkachenko, Mohammad A Alfhili, Jawaher Alsughayyir

|Apr 17, 2025
Mn3O4 Nanocrystal-Induced Eryptosis Features Ca2+ Overload, ROS and RNS Accumulation, Calpain Activation, Recruitment of Caspases, and Changes in the Lipid Order of Cell Membranes.

Yuriy Kot, Volodymyr Prokopiuk, Vladimir Klochkov

|Feb 18, 2025
Long-term adaptation of lymphoma cell lines to hypoxia is mediated by diverse molecular mechanisms that are targetable with specific inhibitors.

Lenka Daumova, Dmitry Manakov, Jiri Petrak

Pageof 3

Frequent Collaborators

5 joint publications

Anton Tkachenko

3 joint publications

Richard Eric Davis

3 joint publications

Pavel Klener

3 joint publications

Kristyna Kupcova